Terpenoid ID | TKC011384 | |
Chirality | TKC151910 | |
Cell line | 0 | |
Protein target | 15 | |
DiseaseNCIT | 0 | |
ORDO | 0 | |
ICD | 23 |
ID | Cell Line | Synonyms | Value | Unit | Type | NCIt | ORDO |
---|---|---|---|---|---|---|---|
TKC011384 | Raji | RAJI; P1-Raji; GM04671 | 60.0 | % | Activity | C27694 | Orphanet_543 |
ID | Uniport | Pref_name | Gene name | value | unit | type |
---|---|---|---|---|---|---|
TKC011384 | P10636 | Microtubule-associated protein tau | MAPT | 39811 | nM | Potency |
TKC011384 | Q9NUW8 | Tyrosyl-DNA phosphodiesterase 1 | TDP1 | 2593 | nM | Potency |
TKC011384 | O95398 | Rap guanine nucleotide exchange factor 3 | RAPGEF3 | 89125 | nM | Potency |
TKC011384 | P53350 | Serine/threonine-protein kinase PLK1 | PLK1 | 18888 | nM | Potency |
TKC011384 | Q14191 | Werner syndrome ATP-dependent helicase | WRN | 50119 | nM | Potency |
TKC011384 | O75164 | Lysine-specific demethylase 4A | KDM4A | 56234 | nM | Potency |
TKC011384 | P27695 | DNA-(apurinic or apyrimidinic site) endonuclease | APEX1 | 39811 | nM | Potency |
TKC011384 | Q962Y6 | Thioredoxin glutathione reductase | TGR | 31623 | nM | Potency |
TKC011384 | Q9UBT6 | DNA polymerase kappa | POLK | 15849 | nM | Potency |
TKC011384 | Q9UNA4 | DNA polymerase iota | POLI | 10000 | nM | Potency |
TKC011384 | P39748 | Flap endonuclease 1 | FEN1 | 50119 | nM | Potency |
TKC011384 | P63096 | Guanine nucleotide-binding protein G | GNAI1 | 10000 | nM | Potency |
TKC011384 | P06746 | DNA polymerase beta | POLB | 17783 | nM | Potency |
TKC011384 | Q9Y253 | DNA polymerase eta | POLH | 7080 | nM | Potency |
TKC011384 | O94925 | Glutaminase kidney isoform, mitochondrial | GLS | 11220 | nM | Potency |
Uniport ID | Uniport Name | ICD-11 |
---|---|---|
P10636 | TAU_HUMAN | Acute myeloid leukaemia [ICD-11: 2A60] |
P10636 | TAU_HUMAN | Alzheimer disease [ICD-11: 8A20] |
P10636 | TAU_HUMAN | Mild neurocognitive disorder [ICD-11: 6D71] |
P10636 | TAU_HUMAN | Choreiform disorder [ICD-11: 8A01] |
P10636 | TAU_HUMAN | Parkinsonism [ICD-11: 8A00] |
P10636 | TAU_HUMAN | Central nervous system disease [ICD-11: 8A04-8D87] |
P10636 | TAU_HUMAN | Neurodegenerative disorder [ICD-11: 8A20-8A23] |
O95398 | RPGF3_HUMAN | Epidermal dysplasias [ICD-11: EK90] |
P53350 | PLK1_HUMAN | Acute myeloid leukaemia [ICD-11: 2A60] |
P53350 | PLK1_HUMAN | Myelodysplastic syndrome [ICD-11: 2A37] |
P53350 | PLK1_HUMAN | Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P53350 | PLK1_HUMAN | Prostate cancer [ICD-11: 2C82] |
P53350 | PLK1_HUMAN | Malignant haematopoietic neoplasm [ICD-11: 2B33] |
P53350 | PLK1_HUMAN | Pancreatic cancer [ICD-11: 2C10] |
P53350 | PLK1_HUMAN | Lymphoma [ICD-11: 2A80-2A86] |
P53350 | PLK1_HUMAN | Nasopharyngeal cancer [ICD-11: 2B6B] |
P53350 | PLK1_HUMAN | Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
Q14191 | WRN_HUMAN | Mature T-cell lymphoma [ICD-11: 2A90] |
P27695 | APEX1_HUMAN | Retinopathy [ICD-11: 9B71] |
P27695 | APEX1_HUMAN | Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P27695 | APEX1_HUMAN | Ocular cancer [ICD-11: 2D00-2D07] |
P27695 | APEX1_HUMAN | Brain cancer [ICD-11: 2A00] |
P27695 | APEX1_HUMAN | Melanoma [ICD-11: 2C30] |
P06746 | DPOLB_HUMAN | Solid tumour/cancer [ICD-11: 2A00-2F9Z] |